John McCabe

Director of Finance/CFO at DEM BioPharma, Inc.

55 year

Health Technology

Commercial Services

Consumer Services

Profile

John McCabe's current job(s) include being an Operating Partner at Longwood Fund Management LLC since 2022 and serving as the Chief Financial Officer/Chief Operating Officer at DEM BioPharma, Inc. since 2022.
His former job(s) include working as the Director-Strategic Business Unit Controller at Biogen, Inc. from 2007 to 2009, serving as the Chief Accounting Officer & Vice President at ARIAD Pharmaceuticals, Inc. in 2013, being the Chief Financial Officer, Secretary & Treasurer at Flex Pharma, Inc. from 2014 to 2019, working as an Audit Manager at Arthur Andersen LLP from 1991 to 2000, serving as the Vice President & Controller at Charles River Associates (Asia Pacific) Ltd.
from 2009 to 2013, and being the Chief Financial Officer, Secretary & Treasurer at Oncorus, Inc. from 2019 to 2022.
Mr. McCabe's education includes an undergraduate degree from Babson College in 1991 and an MBA from the University of Massachusetts in 2009.

John McCabe active positions

Companies	Position	Start
Longwood Fund Management LLC Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts.	Private Equity Investor	2022-03-31
DEM BioPharma, Inc. DEM BioPharma, Inc. Pharmaceuticals: MajorHealth Technology DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022.	Director of Finance/CFO	2022-03-31

All active positions of John McCabe

Former positions of John McCabe

Companies	Position	End
ONCORUS, INC.	Director of Finance/CFO	2022-03-31
Flex Pharma, Inc. Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA.	Director of Finance/CFO	2019-06-30
ARIAD PHARMACEUTICALS, INC.	Comptroller/Controller/Auditor	2014-04-30
Charles River Associates (Asia Pacific) Ltd. Charles River Associates (Asia Pacific) Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Associates (Asia Pacific) Ltd. provides economic, financial, and management consulting services. It is a subsidiary of CRA International, Inc. The company is headquartered in Brisbane, Australia.	Comptroller/Controller/Auditor	2013-04-30
BIOGEN INC.	Corporate Officer/Principal	2009-05-31

See the detail of John McCabe's experience

Training of John McCabe

Babson College	Undergraduate Degree
University of Massachusetts	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John McCabe's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
BIOGEN INC.	Health Technology
ONCORUS, INC.	Health Technology

Private companies	6
Charles River Associates (Asia Pacific) Ltd. Charles River Associates (Asia Pacific) Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Associates (Asia Pacific) Ltd. provides economic, financial, and management consulting services. It is a subsidiary of CRA International, Inc. The company is headquartered in Brisbane, Australia.	Commercial Services
Flex Pharma, Inc. Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA.	Health Technology
ARIAD Pharmaceuticals, Inc. ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA.	Health Technology
Arthur Andersen LLP Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.	Commercial Services
Longwood Fund Management LLC Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts.	Finance
DEM BioPharma, Inc. DEM BioPharma, Inc. Pharmaceuticals: MajorHealth Technology DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022.	Health Technology

See company connections